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Artificial biological pacemakers were developed and tested in canine ventricles. Next steps will
require obtaining oscillations sensitive to external regulations, and robust with respect to long term
drifts of expression levels of pacemaker currents and gap junctions. We introduce mathematical
models intended to be used in parallel with the experiments.
The models describe human mesenchymal stem cells (hMSC ) transfected with HCN2 genes and
connected to myocytes. They are intended to mimic experiments with oscillation induction in a cell
pair, in cell culture and in the cardiac tissue. We give examples of oscillations in a cell pair, in a one
dimensional cell culture and dependence of oscillation on number of pacemaker channels per cell and
number of gap junctions. The models permit to mimic experiments with levels of gene expressions
that are not achieved yet and to predict if the work to achieve this levels will significantly increase
the quality of oscillations. This give arguments for selecting the directions of the experimental work.
PACS numbers:
Introduction
Genetically engineered pacemakers could be developed
as a possible alternative to implantable electronic de-
vices. Several approaches are developing: heterologous
h2-adrenergic receptor expression in pig atria [1], over-
expression of If [2] and dominant negative suppression
of IK1 in guinea pig ventricle [3].
Impressive results were obtained with stem cells to cre-
ate an artificial biological pacemaker [4]: human mes-
enchymal stem cells (hMSC) transfected with HCN2
genes injected in canine left bundle branch provide ven-
tricular escape rhythms that were mapped to the site
of the injection. This experimental success shows great
promises for future therapy.
In a recent review article [5], the question : ”What
characteristics should be embodied in a biological pace-
maker?” was put forward. The creation of a stable phys-
iological rhythm was listed as one of the most important
properties for future biopacemakers. The present article
describes the mathematical models intended to be runned
in parallel with the experiments to achieve this goal.
The oscillations should be reasonably stable with re-
spect to inevitable variations of the parameters affecting
the biological pacemaker. Indeed, many factors can af-
fect the period of the pacemaker namely: decreasing the
expression levels of pacemaker channels or gap junctions,
modification of the peptides regulating gene expressions,
loss of genes, migration of small percentage of stem cells
to other sites or differentiation into other cell types; loss
of pacemaker function by some cells.
In order to obtain a stable pacemaker, many time con-
suming experiments should be performed. In exploring
such systems, we believe that an adequate combination
of experiments with theoretical predictions can lead to
a much faster results, by reaching a better quantitative
understanding and in so doing, in reducing the number of
experiments. To this end, one needs precise and adapt-
able mathematical models based on well-established con-
cepts and results [6]-[23].
The models presented here describe human mesenchy-
mal stem cells (hMSC ) transfected with HCN2 genes and
connected to myocytes. They are supposed to be runned
on a computer mimicking the planned experiments. A
part of these computer simulations can be used instead
of the planned experiments while experiments performed
in parallel with the computer simulations can be used to
update the models.
In the first version of the models, all the complex pro-
cesses mentioned above are condensed into three control
parameters: the number of pacemaker channels per stem
cell, N ; the number of gap junctions per cell, n and the
concentration of the stem cells in the pacemaker.
We demonstrate how they work by mimicking exper-
iments with oscillations induction in a cell pair, in cell
culture and in the cardiac tissue intended to study the
robustness of oscillations and stability of the oscillation
period.
The models permit to easily mimic experiments with
arbitrary levels of gene expressions (including levels not
yet achieved in experiments) and to assess whether
achieving such levels of expression will increase the qual-
ity of oscillations.
Models
Stem cell models
Models for a stem cell hMSC transfected with HCN2
gene were constructed from experimental data [6, 7]. We
focus here on two models: a model, including only in-
activation similar to models of HCN channels by [21],
[13, 15], [16] and a model with two gating variables, acti-
vation and inactivation of the pacemaker current, similar
2to the Hodgkin-Huxley (HH) model [18].
FIG. 1: Stem cell model. a) steady values of activation g1
and inactivation g2. b) time constants.
Stem cell model with inactivation only (Stem-h) is:
dEs/dt = −Nσf g
s
2
[Es − Er]/Cs (1a)
dgs2/dt = [g¯
s
2(Es)− g
s
2]/τ
s
2 (Es) (1b)
Here, Es is the stem cell membrane potential, mV. N
is the number of pacemaker channels per cell, σf ∼ 1pS
is the conductivity of a single pacemaker channel, C∼95
pF is the stem cell capacitance, Er ∼ - 40 mV is the
reversal potential of the HCN2 pacemaker current.
gs2 is a gating variable describing inactivation kinetics
(notation h is used in Hodgkin-Huxley eqns[18]). g¯s
2
(Es)
is its steady value that depends on Es, τ
s
2 (Es) is the
inactivation time constant that depends on Es as well.
The model (Stem-h) is totally defined by two functions
only, g¯s
2
(Es), τ
s
2
(Es); their graphs are shown in Fig.1.
Comment 1. It is possible to use more detailed nota-
tions keeping track that the pacemaking current If con-
sists of two components, INa and IK (e.g., as in [13, 15]).
dEs/dt = If,Na + If,K (2a)
If,Na = gf,Na Y [Es − ENa] (2b)
If,K = gf,K Y [Es − EK ] (2c)
dY/dt = (Y¯ s(Es)− Y )/τ
s
2
(Es) (2d)
But since both components of the current pass through
the same ionic channel and thus are gated by the same
gating variable Y, this description collapses back to Eq.1,
with
Er = [ENa gf,Na + EK gf,K ]/[gf,K + gf,Na] (3)
Comment 2. A model with one gating variable only
(slow inactivation) is used in all descriptions of the HCN
currents that we know. The justification of the above
statement is that the pacemaker current induces oscilla-
tions with period ∼ 1 sec and thus there is no need for
description of processes on a faster time scale.
But this is not a reliable argument. The front of an
AP induced by HCN develops on a much shorter time
scale. To accurately describe HCN effects on it, the
much shorter processes should be taken into account.
So, we developed also a model incorporating two gating
variables, fast activation and slow inactivation (similar
to m and h in HH equations).
Stem cell model with activation and inactivation
(Stem-mh) is:
dEs/dt = −Nσf g
s
1g
s
2(Es − Er)/Cs (4a)
dgsi /dt = (g¯
s
i − g
s
i )/τ
s
i (Es), i = 1, 2 (4b)
Es is the stem cell membrane potential, mV. g
s
1
, gs
2
are
activation and inactivation gating variables (notation
m,h are used in Hodgkin-Huxley eqns[18]). τs
1
, τs
2
are
activation and inactivation time constants, Fig.1.
Different types of myocytes
We need to investigate interaction of stem cells with
myocytes of different types. No published models are
sufficient for this (every model describes a specific type of
myocyte). For this reason, we will content ourselves with
an existing model, which we will modify to reproduce
qualitatively the various types of myocytes.
In this article, we work with several types of myocyte:
ventricular adult myocyte (with high threshold Iosc for
inducing oscillations); self-oscillating neonatal type my-
ocyte and several transitional types. We obtain mod-
els for these myocytes from a model for ventricular my-
ocytes, using different values of expression levels of IK1
current and re-scaling the time constants to keep the ac-
tion potential duration (APD) identical for all myocytes.
So, IK1 is expressed as:
IK1 = k
′ I1K1 (5)
where k′ is the number of IK1 channels per myocyte
and I1K1 is the current through one IK1 channel (averaged
in time).
Our models were derived from the Beeler-Reuter model
(BR) [12], which describes the membrane potential, Em,
3gating variables gmi controlling ionic chanels and Calcium
concentration [Ca]:
∂tEm = −Iion(Em, g
m
i )/Cm +D∇
2Em (6a)
∂tg
m
i = (g¯
m
i − g
m
i )/τ
m
i (Em), i = 1, 6 (6b)
∂t[Ca] = −10
−7iCa + 0.07(10
−7
− [Ca]) (6c)
Here iCa = gCag
m
5
gm
6
(Em−ECa) , gCa = 0.09mS/cm
2
and ECa = −82.3 − 13.0287 ln[Ca]. The diffusion term
D in Eq.6 represents the electric coupling between cells:
D ∼ 10−3cm2/mSec. The model was calculated in one
and two dimensional cases with dx = 0.1mmanddt =
0.02mSec.
A myocyte with k′= 1400 IK1 channels per myocyte
corresponds to the original BR model. We will use
also dimensionless values k = k′/1400. The excitation
threshold is Iexc = 2pA/pF and the oscillation threshold
Iosc = 2.01pA/pF . The myocytes are auto-oscillatory for
k′ <∼ 320 (k <∼ 0.23) and are excitable for k′ >∼ 320.
When k′ approaches from below to the critical value
k′c ∼ 320, the amplitude of the oscillation remains the
same, while the period Tosc of the oscillation diverges
logarithmically Tosc ∼ ln(kc − k), k < kc. This indicates
the change from oscillatory to excitable but quiescent be-
havior occurs through a homoclinic bifurcation [24],[14]).
FIG. 2: Decrease of oscillations period in neonatal
myocytes by HCN2 transfected stem cells. A cell cul-
ture consisting of neonatal self-oscillating cells was simulated.
A record far from the pacemaker region: M- myocytes alone;
MS- stem cells are added. A one dimensional simulation:
201 myocytes with k′= 300 IK1 channels per myocyte, my-
ocytes alone oscillate with period T0=650ms. Stem cells with
N = 105 pacemaker channels per stem cell, n= 1000 gap
junctions are added to the pacemaker region l = 4.3mm long.
They decreased the period to 425 ms.
Cell pair model
A ”cell pair”, consisting of a myocyte and a stem cell
coupled together is described by the following set of equa-
tions :
FIG. 3: Induction of oscillations by a stem cell con-
nected to a myocyte. Myocyte and stem cell potentials
are noted as M and S. Above each image the number of gap
junctions n per cell is shown. a) cells are not connected (n=0),
the myocyte generates one AP only. b) oscillations in the cell
pair. c) disappearance of oscillations when the cell connection
is too strong. Parameters: the number of pacemaker channels
per stem cell N = 1.2 × 105 (see eq.7a), the number of IK1
channels per myocyte k′ = 326 (see eq.5).
∂tEs = −Nσf g
s
2
(Es + 40)/Cs +
nσg(Em − Es)/Cs (7a)
∂tEm = −Iion(Em, g
m
i )/Cm +
nσg(Es − Em)/Cm (7b)
∂tg
m
i = F (g
m
i , Em)/τ
m
i (Em), i = 1, ..., 6 (7c)
∂t[Ca] = −10
−7iCa + 0.07(10
−7
− [Ca]) (7d)
dgs2/dt = F (g
s
2, Es)/τ
s
2 (Es) (7e)
where n is the number of gap junction channels per cell,
σg is the conductivity of a single gap junction channel
(50 pS). Term nσg(Em −Es) in Eq.7a describes current
flowing from a myocyte to a stem cell.
Here, we described the stem cell by the simplified
model Eq.1. The implementation of the full model Eq.4
leads to a very similar system.
Cardiac tissue with incorporated stem cells
We suppose that stem cells are injected to a pacemaker
region only and are connected to myocytes. The tissue
is described by Eqs.6, 7. Inside the pacemaker region, to
Eq.6a, the term nσg(Es − Em) is added, similar to Eq.
7b. Numerically, we considered both a one dimensional
(1D) fiber and a two dimensional (2D) tissue.
Increase of oscillation frequency
in self-oscillatory myocytes.
4FIG. 4: Oscillations phase plane for a cell pair. Bound-
aries of oscillation regions for two models are shown: a model
with inactivation only (model Stem-h, Eq.1) and a model with
activation and inactivation (model Stem-mh, Eq.4). Note
that in both models, high expression levels of gap junctions
or pacemaker channels are not needed to induce oscillations
and may even destroy them.
In experiments [6], stem cells added to cultured neona-
tal myocytes that are self-oscillatory. The stem cells
decreased the oscillation period of these myocytes from
T ∼ 660 to T ∼ 370ms. This phenomenon is easily repro-
duced by the model, both in a cell pair and in a cardiac
tissue, Fig.2.
This decreasing of oscillation frequency by HCN genes
is a robust phenomenon. In addition, it can be observed
at arbitrary values of parameters; only the amount of the
period decrease is parameter dependent.
A large interval of number of pacemaker channels per
cell N and number of gap junction channels per cell n
can be easily investigated. In todays experiments, only
a part of this interval is accessible.
Induction of oscillations in quies-
cent myocytes.
Induction of oscillations in a cell pair
Induction of oscillations by a stem cell connected to
a myocyte is shown in Fig.3. When the cells are not
connected (Fig.3a, n=0), the myocyte can generate one
AP only. When the cells are connected (Fig.3b, n=20),
a pacemaker activity can be initiated in the cell pair. A
diastolic depolarization is observed in the myocytes, and
it generates large amplitude periodic APs.
This result confirms the conjecture, based on results of
experiments with tissues [7], [6], that a stem cell hMSC
transfected with HCN2 gene can induce oscillations in a
cardiac cell.
Disappearance of oscillations
When the cells are too strongly connected (Fig.3c,
n=200), the pacemaker activity decays: the diastolic po-
tential shifts closer to the resting potential of the stem
cell (Er ∼ −40mV ) and the sodium channels are inacti-
vated. This is not a sharp termination of oscillations: the
oscillation amplitude decreases smoothly as the number
of gap junctions n increases. When the amplitude of gen-
erated periodical AP’s is too small, they will be unable
to propagate in cardiac tissue.
In Fig.4 the position of ”disappearance of oscillation”
boundary was chosen at parameter values where the up-
stroke of the AP decreases below ∼ 0 mV and the ampli-
tude of oscillations becomes inferior ∼ 50 mV. It would
be more accurate to determine when the propagation will
disappear using cardiac tissue models.
Robustness of oscillations.
As we observed from the example above, oscillations
in excitable cardiac cells can be induced not for all pa-
rameter values.
In Fig.4 phase plane for a cell oscillation pair is shown.
It is seen that oscillations are not observed at low values
of number N of pacemaker channels per cell and num-
ber n of gap junction channels per cell. When n, N are
increasing, oscillations arrive as a jump, with full ampli-
tude but with a very high oscillations period (several sec-
onds). The period decreases and becomes normal when
N,n continue increasing. It is the same homoclinic bifur-
cation [24] that describes the transition from oscillatory
to excitable but quiescent behavior when expression level
of IK1 is increased.
At the contrary, when oscillations disappear in a cell
pair, there is no jump: amplitude of oscillations slowly
decrease while values of n, N increasing too large.
Fig.4 shows the oscillation boundaries for two models:
the model comprising inactivation gating variable only as
in majority of the descriptions published (model Stem-h),
and the model comprising both gating variables, activa-
tion and inactivation (model Stem-mh). Since the ratio
ǫ = τs
1
/τs
2
≪ 1 (Fig. 1b), it is natural to expect that a
simplified model with inactivation only will give results
close to the full model. As illustrated in Fig.4 the results
are qualitatively but not quantitatively similar.
As seen in Fig.4 the induced oscillations are robust:
they exist for a wide range of parameters: number of gap
junctions per cell n and number of pacemaker channels
per cell N . This is important to consider for constructing
a biological pacemaker.
Cell pair experiments. Induction of oscillations in a
cell pair experiment was not demonstrated yet. What is
the reason? A possible explanation : Expression of gap
junctions in a cell pair (∼ 100 gap junctions/cell) is 1-2
orders of magnitude less than in a normal cardiac tissue.
Then, a path to induce oscillations in a cell pair might
be increasing the expression of gap junctions.
As Fig.4 show, approximately 100 gap junctions per
cell is well enough for induction of oscillations. The mod-
els show that :
- an experimental path intended to increase the expres-
sion of gap junctions will not give positive results.
5- selecting myocytes with not high level of expression
of IK1 will result in oscillations.
Conclusions
1. Mathematical models of stem cells (hMSC) trans-
fected with HCN2 genes and connected to myocytes were
developed. This opens a way to investigate the induction
of oscillation and its robustness in a cell pair, in cell cul-
ture and in the three dimensional cardiac tissue.
2. The mathematical results confirm the conjecture,
based on experiments with tissues, that stem cells can
induce oscillation even in myocytes that do not self- os-
cillate. The oscillations are robust and well suited for
creation of biological pacemakers (Fig.4).
3. To induce oscillations in a cell pair, there is no need
to increase expression levels of gap junctions or of HCN
genes (Fig.4).
4. The models have a potential to eliminate a part
of time consuming genetical and electrophysiological ex-
periments needed for developing a biological pacemaker.
They also permit to estimate the effects of expression
levels that are not achieved in the experiments yet (Figs.
4).
Acknowledgment The authors acknowledge the
helpful discussions with Claudia Altomare, M. Boyet, I.
S. Cohen, Halina Dobrzynski, F. Fenton, M. Mangoni,
H. Ohmori, D. Pazo, S. Takagi, C. Ulens.
[1] Edelberg JM, Huang DT, Josephson ME, Rosenberg RD.
Molecular enhancement of porcine cardiac chronotropy.
Heart 2001;86:559 562.
[2] Qu J, Barbuti A, Protas L, Santoro B, Cohen IS, Robin-
son RB. HCN2 overexpression in newborn and adult
ventricular myocytes: distinct effects on gating and ex-
citability. Circ Res. 2001 Jul 6;89(1):E8-14.
[3] Miake J, Marbn E, Nuss HB. Gene therapy: bio-
logical pacemaker created by gene transfer. Nature.
2002;419:132133.
[4] Plotnikov AN, Sosunov EA, Qu J, Shlapakova IN,
Anyukhovsky EP, Liu L, Janse MJ, Brink PR, Cohen
IS, Robinson RB, Danilo P, Rosen MR. Biological Pace-
maker Implanted in Canine Left Bundle Branch Provides
Ventricular Escape Rhythms That Have Physiologically
Acceptable Rates. Circulation. 2004;109:506-512.
[5] Rosen M, 15th annual Gordon K. Moe Lecture. Biolog-
ical pacemaking: in our lifetime? Heart Rhythm. 2005
Apr;2(4):418-28.
[6] Potapova I, Plotnikov A, Lu Z, Danilo P, Jr, Valiunas V,
Qu J, Doronin S, Zuckerman J, Shlapakova IN, Gao J,
Pan Z, Herron AJ, Robinson RB, Brink PR, Rosen MR,
Cohen IS. Human Mesenchymal Stem Cells as a Gene
Delivery System to Create Cardiac Pacemakers. Circula-
tion. 2004;94:952-959.
[7] Cohen IS, private commnication, 2. 20. 2005
[8] Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuck-
erman J, Walcott B, Robinson RB, Rosen MR, Brink
PR, Cohen IS. Human mesenchymal stem cells make car-
diac connexins and form functional gap junctions. 2004.J
Physiol 555.3 pp 617-626.
[9] Rosen MR, Brink PR, Cohen IS, Robinson RB. Genes,
stem cells and biological pacemakers. Cardiovascular re-
search. 2004; 64 : 12-23.
[10] Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti
R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, Gep-
stein L. Electromechanical integration of cardiomy-
ocytes derived from human embryonic stem cells. 2004;
doi:10.1038/nbt1014.
[11] Qu J, Kryukova Y, Potapova IA, Doronin SV, Larsen M,
Krishnamurthy G, Cohen IS, Robinson RB. MiRP1 mod-
ulates HCN2 channel expression and gating in cardiac
myocytes. J Biol Chem. 2004 Oct 15;279(42):43497-502.
[12] Beeler GW, Reuter H. Reconstruction of the action po-
tential of ventricular myocardium fibers. J Physiol.1977;
268:177-210.
[13] Kurata Y, Hisatome I, Imanishi S, Shibamoto T. Dynam-
ical description of sinoatrial node pacemaking: improved
mathematical model for primary pacemaker cell. Am J
Physiol Heart Circ Physiol. 2002 Nov;283(5):H2074-101.
[14] Kurata Y, Hisatome I, Matsuda H, Shibamoto T. Dy-
namical Mechanisms of Pacemaker Generation in IK1-
Downregulated Human Ventricular Myocytes: Insights
from Bifurcation Analyses of a Mathematical Model Bio-
phys. J. 2005 89: 2865-2887.
[15] Zhang H, Holden AV, Kodama I, Honjo H, Lei M,
Varghese T, Boyett MR. Mathematical models of ac-
tion potentials in the periphery and center of the rabbit
sinoatrial node. Am J Physiol Heart Circ Physiol. 2000
Jul;279(1):H397-421.
[16] Azene EM, Xue T, Marban E, Tomaselli GF, Li RA. Non-
equilibrium behavior of HCN channels: insights into the
role of HCN channels in native and engineered pacemak-
ers. Cardiovasc Res. 2005 Aug 1;67(2):263-73.
[17] Gepstein L. Derivation and potential applications of hu-
man embryonic stem cells. Circ Res. 2002; 91:866876.
[18] Hodgkin AL, Huxley F. A quantitative description of
memebrane current and it’s application to conduction
and excitation in nerve. J Physiol. 1952; 117:500-544.
[19] Valiunas V, Weingart R, Brink PR. Formation of het-
erotypic gap junction channels by connexins 40 and 43.
Circ Res. 2000;86:e42e49.
[20] Moosmang S, Stieber J, Zong X, Biel M, Hofmann F,
Ludwig A. Cellular expression and functional charac-
terization of four hyperpolarization-activated pacemaker
channels in cardiac and neuronal tissues. Eur J Biochem.
2001;268:16461652.
[21] Accili EA, Proenza C, Baruscotti M, DiFrancesco D.
From Funny Current to HCN Channels: 20 Years of Ex-
citation. J Physiol. News Physiol Sci 17: 32-37, 2002.
[22] Yu H, Wu J, Potapova I, Wymore RT, Holmes B, Zuck-
erman J, Pan Z, Wang H, Shi W, Robinson RB, El-
Maghrabi MR, Benjamin W, Dixon J, McKinnon D, Co-
hen IS, Wymore R. MinK-Related Peptide 1, A β Sub-
unit for the HCN Ion Channel Subunit Family Enhances
Expression and Speeds Activation. Circulation Research.
2001;88:e84.
[23] Moore LK, Burt JM. Gap junction function in vascular
smooth muscle: influence of serotonin. Am J Physiol.
1995 Oct;269(4 Pt 2):H1481-9.
6[24] Pumir A, Arutunyan A, Krinsky V, Sarvazyan N. Gen-
esis of ectopic waves: role of coupling, automaticity and
heterogeneity. Biophys. J, to appear.
[25] Bender CM, Orszag SA. Advanced mathematical meth-
ods for scientists and engineers, Mac Graw Hill, Singa-
pore (1984).
[26] Abramowitz M, Stegun IA. Handbook of mathematical
functions. Dover, 1972.
